Global Audience

With an audience over 150,000 visitors per month, Pharmalicensing is a leading destination for decision makers within the pharmaceutical and biotech licensing community. Covering the full spectrum of the industry, from large pharmaceutical companies to small biotech companies along with academic institutions, Pharmalicensing users offer a true reflection of the industry, its trends and interests.

Over half of the Pharmalicensing audience is made up of the industry's most senior decision makers, CEO's, Chairmen, VP's, Licensing and Business Development Managers, ensuring the right people are looking at your opportunities.

The average visitor numbers to Pharmalicensing during H109 increase by 28% compared to H108, rising to a monthly average of 156,346 visitors compared to an average of 122,401 visitors during the same period in 2008.

Maximising your chance of finding partners, the Pharmalicensing audience is truly global. Covering USA (40%), Europe (28%), Asia and Australasia (24%) and the rest of the world (8%), our services introduce your company and opportunities to new arenas and contacts.